Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our ...

Vertex holds a dominant position in the cystic franchise (“CF”) market. Its CF sales continue to grow, driven by higher sales of Trikafta/Kaftrio in younger age groups. Vertex’s CF product ...

Vertex's cloud growth momentum remains strong, with a 27% y/y increase in 4Q24. Read more to see why I upgrade VERX stock ...

Most of the focus in generative AI has been on text-based ... 3 — its speech-to-text and HD text-to-speech models — to its Vertex AI development platform starting next week.

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to trigger sufficient levels of insulin production in a phase 1/2 trial.

As digital habits become harder to break, this one simple setting tweak can offer a powerful way back to better focus and mental strength. The science is clear: reducing mobile internet access can ...

Goldman Sachs analyst Adam Hotchkiss expressed expectations on Vertex, Inc. (NASDAQ ... the analyst anticipates that management will focus on addressing several key points, including the ...

Sensate focus is a sex therapy technique for exploring the sensations of touch and improving physical intimacy between partners. Dr. William Masters and Virginia Johnson developed sensate focus in ...

Apple's "Focus" feature is a powerful tool for cutting down on distractions and interruptions on a per-task basis, but setting up different Focus options takes some time investment and tinkering ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Parents can help children improve focus and discipline by setting timers, breaking tasks into smaller steps, and using checklists. Additionally, employing signals for attention redirection ...